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INTRODUCTION
The "autonomy" of neoplastic tissue is intimately related to its ability to
carry out net synthesis of protein regardless of the demands of the host.
Clinically, this is manifest in the failure of the tumor to exhibit the wasting
of other tissues of the cachectic host. Accordingly, Mider and others"8 have
referred to tumors as "nitrogen traps." In experiments of LePage et al.1'
on this subject, the weight of most nontumor tissues of fasted tumor-
bearing rates diminished to 30-50%o of values for control tissues. On the
other hand, the increase in weight of tumors was not significantly different
in fasted animals and those fed ad libitum. Moreover, the uptake of C14 in
proteins of the tumors was equal in rate and quantity in fed and fasted
tumor-bearing rats following injection of glycine-2-C'4.
Among the possible explanations for these clinical and laboratory find-
ings, two have been investigated recently, namely, the possibility that
tumors might have a peculiarly great avidity for amino acids of the blood
and the possibility that tumors might take up plasma proteins directly.
Initial evidence that tumors exhibited a greater uptake of amino acids came
from the studies of Zamecnik et al.' who reported that hepatoma slices
incorporated isotope of labeled alanine into protein at a rate eight times that
of slices of normal liver or liver of the hepatoma-bearing rat. These findings
have been confirmed by Winnick et al.,' but they are in sharp contrast to
the results obtained after injection of labeled amino acids into tumor-
bearing rats. In 1944 Shemin and Rittenberg17 found that uptake of N15-
labeled amino acids into protein in vivo was not greater in tumors than in
other tissues and their findings were subsequently confirmed for a variety
of tumors by Zamecnik et al.," Norberg and Greenberg,1' and others; the
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present studies provide further confirmation of the results of Shemin and
Rittenberg.
Utilization of plasma protein as a source of amino acids was demon-
strated by Whipple and Madden who infused plasma into fasted dogs and
maintained their nitrogen balance.' In the normal animal, the rate of turn-
over of plasma proteins is rapid, as is indicated by the turnover time of 8.2
days for albumin in the rat."9 While these findings have indicated that
plasma proteins are utilized by nontumor tissues, evidence has only
recently been presented for concentration of plasma protein in tumors.
Korngold and Pressman11 reported localization of antibodies labeled with
1131 in the Murphy-Sturm lymphosarcoma and Wagner's has found that
virus in tumors is destroyed as the antibody level of the host rises. Babson
and Winnick1 noted a greater uptake of isotope of biosynthetically-labeled
plasma proteins by tumors than by liver and kidney. They found that the
relative specific activities of two labeled amino acids was the same in
plasma proteins and proteins of tumors and, further, the labeling of tumor
protein was not affected by injection of large quantities of non-radioactive
amino acids.
Our interest in this subject has developed from two lines of investigation.
In studies on the metabolism of acetate-i-C14 and pyruvate-2-C14 in tissues
of tumor-bearing rats, it was found that nontumor tissues rapidly trans-
ferred the isotope to amino acids. In experiments with acetate-1-C14, the
isotope in nontumor tissues was found chiefly in glutamic acid and in
experiments with pyruvate-2-C14, the isotope in nontumor tissues was
found chiefly in glutamic acid and alanine.2"8 On the other hand, the
tumors studied did not metabolize acetate-i-C14 and transferred the isotope
of pyruvate-2-C14 primarily to lactate. These experiments suggested that
the tumors might be dependent upon other tissues for their supply of
<'non-essential amino acids" for protein synthesis.
Another suggestive line of investigation9 concerned transplantation ex-
periments involving the Shope papilloma. It was found that adult rabbit
skin infected in vitro with the Shope virus and transplanted to the brains
of immune rabbits developed papillomas containing infectious virus. In like
manner, the infectivity of the virus remained unchanged in domestic rabbit
papillomas reinfected in vitro, despite growth in immune animals. In con-
trast, no evidence of virus could be found in the V2 carcinoma (the malig-
nant tumor derived from the Shope papilloma) after similar treatment
although infectious virus could be recovered after growth in normal non-
immune rabbits. These results suggest that antibody failed to penetrate the
cells of normal skin or of benign papilloma but did penetrate the cells of
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the carcinoma and indicate that the transformation to cancer was associated
with an increased permeability of cell walls.
The experimental questions which arose from these studies were:
(i) could tumors take up plasma protein to a greater extent than other
tissues, and (ii) could the tumors utilize these proteins for growth?
MATERIALS AND METHODS
The animals used in these experiments were male Sprague-Dawley rats weighing
150-200 grams. They were obtained from the Charles River Laboratories in Boston,
Massachusetts, and were fed ad libitum on Purina Laboratory Chow. The Walker 256
carcinosarcoma and Jensen sarcoma used in these experiments were transplanted by
Mrs. Rose K. Busch. The tumors were transplanted 7-9 days prior to the experiment
-and weighed 3-5 grams in the aggregates of 2-4 sites of transplantation.
Glycine-2-C"' and DL-lysine-2-C'4, with specific activities of 19 microcuries per mg.
and 3.3 microcuries per mg. respectively, were obtained from Tracerlab, Inc. In studies
on the uptake of radioactive amino acids, 0.5 mg. of labeled glycine or 1 mg. of labeled
lysine* was injected intraperitoneally into tumor-bearing rats. For preparation of the
radioactive plasma, 2 mg. of labeled glycine or 10 mg. of labeled lysine were injected
intraperitoneally into normal rats weighing 250-350 grams. At the end of the desired
interval, generally three hours, the rats were anesthetized with nembutal (0.5 mg./100
grams body weight) and exsanguinated by arterial puncture at the bifurcation of the
aorta by means of a 20 ml. syringe and a 19-gauge needle; 0.25 ml. of heparin (5000
U./ml.) were added to the syringe. The heparinized whole blood was centrifuged at
1500 r.p.m. for 10 minutes and the supernatant plasma was dialyzed for a minimum of
two hours against a buffer of 0.1 M glycine or DL-lysine and 0.01 M sodium phosphate
buffer at pH 7.4. An average of 375,000 c.p.m. (counts per minute) was found in
5 ml. of plasma and the average specific activity of the plasma protein was 1100
c.p.m./mg. At three hours after intravenous injection of 3-5 ml. of the radioactive
plasma into tumor-bearing rats, the average specific activity of plasma proteins of the
recipient rats was 280 c.p.m./mg.
At the selected time, the tumor-bearing rats receiving the radioactive tracer were
anesthetized with nembutal and exsanguinated as noted above. The tissues were excised
and placed in liquid air' except in experiments in which the cellular particulates were
isolated by differential centrifugation. Following dispersion of the tissues in perchloric
acid, the precipitated proteins were treated! with 5% trichloroacetic acid, 95% ethanol,
ethyl ether, chloroform-methanol (2: 1) twice,18 petroleum ether-acetone (1: 1), and
butanol. The suspension of protein in butanol was placed on an alundum disk in a
separated glass funnel on a filter flask connected to a vacuum line; suction was
applied until the plate was dry. Radioactivity was determined in a preflush flow
counter.
In experiments involving differential centrifugation of the homogenates, the excised
tissues were placed in ice-cold saline and then dispersed in 0.3 M sucrose. The pro-
cedures used in preparation of nuclear and mitochondrial fractions were essentially
* The authors are indebted to Dr. D. M. Bonner for initial samples of these amino
acids.
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those of Schneider"6 and were carried out in a model PR-2 International refrigerated
centrifuge. The microsomal fraction was prepared by centrifugation of the sample in a
Spinco preparative centrifuge in an average gravitational field of 60,000 g for one
hour.'O*
RESULTS
Figure 1 presents the rates of labeling of proteins of liver, Walker 256
carcinosarcoma, kidney, Jensen sarcoma, and skeletal muscle following
injection of glycine-2-C14. These data are in agreement with those of previ-
ous reports"'7 which have indicated that uptake of isotope of amino acids
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FIG. 1. Rates of labeling of tissue protein following injection of glycine-2-C'. Data
are averages of two to four experiments carried out at each time point.
FIG. 2. Specific activities of protein of tissues three hours after intraperitoneal
injection of glycine-2-C". Values for the Jensen sarcoma and Walker 256 carcinosar-
coma are pooled. Specific activities of protein of heart, testis, thymus, and brain
ranged between those of muscle and kidney.
by protein of tumors is not significantly different from that of nontumor
tissues. While the increase in specific activity of protein of the rapidly
growing Walker 256 carcinosarcoma was equal to that of liver, values for
protein of the Jensen sarcoma, a more slowly growing tumor, were lower
than those of liver or kidney. The curves reached a plateau in the 3-6-hour
interval. The specific activity of proteins of skeletal muscle was very low
throughout the study. Figure 2 presents specific activities of protein of
various tissues three hours after injection of glycine-2-C14. It is apparent
that the values for the tumors are within the range for those of other
tissues. The specific activities of protein of the spleen, plasma, whole
intestine and pancreas were all significantly greater than those of the
* We are indebted to Drs. D. M. Bonner and J. H. Milstone for the use of their
Spinco ultracentrifuges.
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tumors at this time. It is of interest that Friedberg et al.8 have shown that
values for intestinal mucosa were much higher than those of kidney, liver,
or plasma, and slightly higher than pancreas. The specific activities of pro-
teins of the heart, testis, thymus, and brain were determined at three hours
after injection of the labeled glycine and these values ranged between those
of muscle and kidney (Fig. 2). In studies with DL-lysine-2-C14, essentially
the same findings were obtained three hours after injection of the tracer.
The specific activity of protein of the Walker 256 carcinosarcoma approxi-
mated that of liver or spleen (Fig. 1), while the specific activity of protein
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FIG. 3. Rates of labeling of tissue protein following injection of labeled plasma.
Values for the Jensen sarcoma and Walker 256 carcinosarcoma were pooled inasmuch
as significant differences were not found. The specific activity of the plasma proteins
of the recipient rats varied from 180-330 c.p.m,/mg. with an average value of
280 c.p.m./mg.
FIG. 4. Specific activity of protein of tissues three hours after injection of plasma
labeled with glycine-2-C'. Values for Walker 256 carcinosarcoma and Jensen sarcoma
are pooled. Specific activities of protein of intestine, brain, testis, and lung ranged
from 1.7-8.2 c.p.m./mg. and fall between those of muscle and pancreas.
of the pancreas was three to four times that of protein of the spleen (Fig.
2). Values for lung,,kidney, and muscle decreased in the same order as
with glycine-2-C14.
PLASMA PROTEIN
The rates of uptake of isotope of plasma protein by protein of tissues is
indicated in Figure 3. The specific activity of protein of the tumors in-
creased steadily in the first four hours after injection of the labeled plasma;
no significant differences were found in the data for the Jensen sarcoma and
the Walker 256 carcinosarcoma. The rate of increase of the specific activity
of protein of the tumors was 23/2-10 times that of other tissues (Fig. 3).
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The curves for kidney and spleen reached a plateau in the 3-6-hour period,
while that for liver began to decline after the third hour. The specific activ-
ity of protein of skeletal muscle was very low at each time point studied. At
three hours after injection of the labeled protein, values for the specific
activity of protein of the tumor were 3541 c.p.m./mg. (Fig. 4) compared
with a range of 11-14 c.p.m./mg. for heart, diaphragm, spleen, kidney,
thymus, and liver. Values for intestine, brain, testis, and lung ranged from
1.7-8.2 c.p.m./mg. and would appear in Figure 4 between pancreas and
TABLE 1. LABELING OF INTRACELLULAR PARTICULATES FOLLOWING INJECTION
OF LABELED PLASMA
Values are c.p.m./mg. protein of the particulates and supernatant solutions.
Methods of preparation of microsomal and mitochondrial fractions are in the
text. Each value in the table is the average of four experiments, two with
glycine-2-C1' labeled plasma and two with DL-lysine-2-C1' labeled plasma.
Values are pooled inasmuch as no significant differences were found for the
experiments with the two labeled amino acids. Ranges are presented in
parentheses.
Whole Mitochondrial Microsomal Supernatant
Tissue homogenate fraction fraction fraction
Walker 256
carcinosarcoma 32.4(21.8-43.6) 26(20.2-36.9) 29.5(18.4-46.0) 54(22.4-77.0)
Liver 11.2(10.0-11.8) 11.5(7.4-17.6) 10.5(9.3-11.5) 25(8.7-49.2)
Kidney 13.1(10.5-14.7) 8.6(6.4-9.7) 9.1(6.8-10.2) 41(14.1-39.7)
Lung 58.8(27.4-95) 26(9.2-45) 11:1(6.7-18) 99(52.4-146)
muscle. The specific activities of protein of the lung varied markedly, i.e.,
from 11 c.p.m./mg. to 75 c.p.m./mg., and were occasionally highest of the
tissues studied. This variation may be due to the relatively large amount of
blood or plasma pooled in the very small lung tissue mass or the uptake of
protein aggregates by lung. In agreement with the values obtained for
plasma labeled with glycine-2-CI4, the specific activity of protein of the
Walker 256 carcinosarcoma was two to three times that of liver or
kidney, three hours after injection of plasma protein labeled with DL-
lysine-2-C14.1
LABELING OF CELLULAR PARTICULATES IN VIVO
The possibility that isotope of plasma protein entered the protein of
intracellular particulates was investigated by determination of the specific
activity of proteins of these particulates after tissue homogenates had been
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subjected to differential centrifugation."0'1 Table 1 presents the specific
activities of proteins of cellular particulates of Walker 256 carcinosarcoma,
kidney, liver, and lung. Values for the nuclear fractions are not presented
inasmuch as they closely reflected values of the whole homogenates; in
these experiments no special precautions were taken for purification of the
nuclei. The specific activities of proteins of the mitochondrial, microsomal,
and supernatant fractions were sufficiently similar in experiments with
either labeled glycine or lysine that the data were pooled in Table 1. The
TABLE 2. LABELING OF INTRACELLULAR PARTICULATES BY INCUBATION
WITH LABELED PLASMA
In these experiments, 0.5 and 1.0 ml. of labeled plasma were incubated with
homogenates of tissues over a range of times with no significant changes in
the labeling. Values presented are specific activities of proteins of particulates
and supernatant solutions.
Ml. labeled Whole Mitochondrial Microsomal Supernatant
Tissue plasma homogenate fraction fraction fraction
Tumor 0.5 106 39 70 350
1.0 264 78 154 508
Liver 0.5 66 38 37 166
1.0 161 82 103 340
Kidney 0.5 210 49 59 818
1.0 345 90 103 ...
Lung 0.5 390 119 43 930
1.0 660 95 207 880
data for mitochondria reflect the same trends as those for microsomes with
the exception that the average value for lung was equal to that for tumor,
although the variation was very great. The control experiments for these
studies are presented in Table 2. Inasmuch as the labeling of protein of the
particulates could have occurred by adherence of plasma proteins to mito-
chondrial and microsomal preparations or by precipitation of particles, such
as small clumps of fibrin, from plasma in the same gravitational field as the
cellular particulates, it was necessary to determine the extent of these
processes before a conclusion could be reached on the incorporation of
plasma proteins or their degradation products into the particulates.*
Accordingly, varying amounts of labeled plasma were incubated with
homogenates of liver, kidney, lung, and tumor for varying intervals, and
* We are indebted to Dr. G. A. LePage for helpful suggestions on this point.
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the specific activity of the cellular particulates was determined as in the
in vivo experiments (Table 2). From these studies, ratios could be obtained
for the relative specific activities of proteins of the particulates and those of
the supernatant fraction. In tumors, the ratio of the specific activity of pro-
tein of the mitochondrial fraction to that of the supernatant fraction varied
from 1: 7 to 1: 9, and the corresponding values for the microsomal frac-
tion were 1: 3.5 to 1: 5 in the in vitro studies. Since the specific activity of
protein of the supernatant fraction of the tumor was 54 c.p.m./mg. in the
in vivo experiments (Table 1), the maximal in vitro labeling which could
occur if all the isotope were in plasma protein would be 6.7 c.p.m./mg. for
protein of the mitochondria and 13.5 c.p.m./mg. for protein of the micro-
somes. Accordingly, the minimal extent of labeling in vivo was 19.3 c.p.m./
mg. for protein of tumor mitochondria and 16 c.p.m./mg. for protein of
tumor microsomes. For the mitochondria of liver, kidney, and lung, the
corresponding values were 5.7, 4.6, and 14.4 c.p.m./mg., respectively. For
the microsomes, the corresponding values were 4.8, 4.1, and 3.5 c.p.m./mg.
for liver, kidney, and lung, respectively. It would thus appear that labeling
of the protein of the mitochondria of tumors was 3.5 and 4.2 times that of
liver and kidney, respectively, while the labeling of microsomes of tumor
was 3.5 to 4.8 times that of liver, kidney, and lung. These data suggest that
the tumor is not only more effective in trapping radioactive plasma, but is
also more effective than other tissues in its utilization.
DISCUSSION
These initial experiments indicate a greater labeling of "tumor protein"
than proteins of other tissues following injection of radioactive "plasma." It
is clear that both "tumor protein" and "plasma" represent complex mix-
tures of proteins and other compounds. From the studies of Cohn and his
co-workers,6 it is evident that there are many kinds of proteins in plasma
and undoubtedly even the number of different antibodies is large. In experi-
ments now in progress, radioactive plasma proteins are being separated by
the methods developed by Cohn et al.6 and the isolated fractions are being
reinjected into tumor-bearing rats. It remains to be determined whether one
or many protein fractions contribute to the labeling of proteins of the
tumor. On the other hand, "tumor protein" is a mixture of compounds
which share the properties of insolubility in protein precipitants and organic
solvents used for extraction of lipids. The nature of the proteins which are
the recipients of the isotope of radioactive plasma has not been studied, but
it seems possible that only a part of the proteins of the tumor can be syn-
thesized from products of plasma proteins. In this case, an extensive study
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of the labeling of individual proteins of the tumor would be justified. Before
an understanding of the mechanism of utilization of the plasma proteins
can be achieved, specific proteins of tumors will have to be isolated and
degraded. These studies do not permit evaluation of the extent of degrada-
tion of plasma protein before the fragments are incorporated into tumor
protein.
While the possibility exists that the avidity displayed by the tumors for
plasma protein reflects a permeability difference between tumors and other
tissues,7 either at the cellular level or at the level of tissue structure, the
evidence presented indicates that there is transfer of isotope to cellular
particulates in vivo. Moreover, it is possible to calculate that 1000 mg. of
tumor protein could take up 1030 mg. of plasma protein in 24 hours, an
amount sufficient to account for the known doubling in weight of the tumor
in this time interval.'2 Thus, in three hours, the specific activity of protein
of the tumor was 36 c.p.m./mg. so that one gram of tumor protein would
take up 3.6 x 104 c.p.m. in three hours. Since the specific activity of plasma
protein of recipient rats averaged 280 c.p.m./mg., 3.6 x 104 c.p.m. repre-
sents an uptake of 128 mg. of plasma protein in three hours. If this rate
were constant, one gram of tumor protein would take up 1030 mg. of
plasma protein in 24 hours. These considerations are based on values for
the whole homogenates. Although similar calculations for the uptake of
amino acids are difficult because of the unknown size of the pool diluting
the radioactive precursor, it is possible to calculate the percentage of isotope
of glycine-2-C'4 or lysine-2-C14 injected which enters the tumor protein. Of
the 11,000,000 c.p.m. of labeled amino acid injected, 200,000 c.p.m. can be
accounted for in 500 mg. of tumor protein (average specific activity equals
400 c.p.m./mg.). This value represents 1.8% of the total amino acid in-
jected. On the other hand, 18,000 c.p.m. of 375,000 c.p.m. in the injected
plasma protein were found in the tumor. At three hours, an average of
245,000 c.p.m. remain in the plasma and accordingly the tumor has
removed 12.8%o of the isotope lost from the plasma.
These experiments may be of significance in three aspects of the study of
neoplasia. First, the growth of the tumor in the starving animal and
cachectic human may be related to its ability to trap plasma protein and
utilize the degradation products for synthesis of tumor protein. Secondly,
the ability of the tumor to invade and metastasize may reflect its more
favorable nutritional requirements or conversely, the ability of the tumor to
take up label of plasma protein may reflect cellular changes important to
invasion and metastasis. Finally, the factors involved in concentration of
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the plasma protein may be related to differences between benign and malig-
nant tumors in that the former may not effectively take up plasma proteins.
SUMMARY
1. The rate of uptake of isotope of glycine-2-C14 and DL-lysine-2-CA4
by proteins of tumors was in the range for nontumor tissues over the
period of 45 minutes to 6 hours following intraperitoneal injection of the
isotope.
2. The rate of uptake of isotope of plasma proteins labeled with glycine-
2-C14 or DL-lysine-2-CI4 by tumor protein was 2X2 to 10 times that of
other tissues studied, with the exception of lung which gave variable results.
3. Labeling of microsomal fraction of tumor was 3.5 to 4.8 times greater
than that of kidney, liver, and lung three hours after intravenous injection
of labeled plasma protein.
4. Labeling of the mitochondrial fraction of tumors was 3.5 to 4.2 times
greater than that of kidney and liver respectively three hours after intra-
venous injection of labeled plasma protein.
5. It can be calculated from the data on labeling of tumor protein that
uptake of plasma protein could account for the doubling of the weight of
tumors in 24 hours.
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